Loading...
XSHG
603363
Market cap1.69bUSD
Dec 05, Last price  
4.59CNY
1D
1.77%
1Q
-2.34%
IPO
-21.38%
Name

Fujian Aonong Biological Technology Group Incorporation Ltd

Chart & Performance

D1W1MN
XSHG:603363 chart
P/E
20.62
P/S
1.36
EPS
0.22
Div Yield, %
Shrs. gr., 5y
9.63%
Rev. gr., 5y
8.65%
Revenues
8.76b
-54.97%
2,953,809,5214,184,442,7044,012,709,1174,978,470,5984,902,660,0985,761,891,9485,788,080,06711,517,165,75718,038,160,16021,613,039,52119,457,641,1318,762,672,800
Net income
579m
P
24,991,36442,745,07133,776,93691,375,506108,118,86630,125,654100,356,032993,605,03300-3,650,822,227579,345,018
CFO
-117m
L
00129,237,958128,952,36826,775,90027,261,152394,159,196406,022,923524,291,286663,636,691984,006,832-116,781,234
Dividend
Jun 08, 20210.15 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig raising, raw materials trade, agricultural internet, bio-pharmaceutical, and other businesses in China and internationally. The company researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant feed, and other products; operates pig breeding farms; and engages in the pig slaughtering and processing activities. It also provides vaccines, veterinary drug preparations, micro ecological preparations, powders, premixes, oral liquids, additives, disinfectants, and other products, as well as creates intelligent breeding service platform. The company was founded in 2011 and is based in Xiamen, China.
IPO date
Sep 26, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT